Literature DB >> 10605794

Hemostatic factors and inflammatory disease.

J L Degen1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10605794

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

1.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

Review 2.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

3.  Role of the coagulation system in the pathogenesis of sickle cell disease.

Authors:  Md Nasimuzzaman; Punam Malik
Journal:  Blood Adv       Date:  2019-10-22

4.  Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

Authors:  Aparna Krishnamoorthy; Amrendra Kumar Ajay; Dana Hoffmann; Tae-Min Kim; Victoria Ramirez; Gabriela Campanholle; Norma A Bobadilla; Sushrut S Waikar; Vishal S Vaidya
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

Review 5.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Fibrin-mediated protection against infection-stimulated immunopathology.

Authors:  Lawrence L Johnson; Kiera N Berggren; Frank M Szaba; Wangxue Chen; Stephen T Smiley
Journal:  J Exp Med       Date:  2003-03-10       Impact factor: 14.307

7.  Genetic association of urokinase-type plasminogen activator gene rs2227564 site polymorphism with sporadic Alzheimer's disease in the Han Chinese population.

Authors:  Xuelian Ji; Longfei Jia; Jianping Jia; Li Qi
Journal:  Neural Regen Res       Date:  2012-10-25       Impact factor: 5.135
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.